ABSTRACT We have shown that skin fibroblasts from patients with cystic fibrosis (CF) and from carriers for CF [heterozygotes (HZ)] consume more 02 than do their controls. When the mitochondrial electron transport inhibitor rotenone was added to the cells, the relative inhibition of 02 consumption was CF > HZ > controls (P < 0.005 in both comparisons). Because rotenone specifically inhibits NADH dehydrogenase, [NADH:
Since its identification as a distinct entity, cystic fibrosis (CF) has been a genetic and pathogenetic enigma. The disease is transmitted within families as an autosomal recessive trait, affected individuals possessing a double dose of the mnutant gene. Biological parents of subjects with CF possess a single dose of the mutant gene and, by definition, are obligatory carriers for the condition. However, carriers are clinically normal and their detection prior to the birth of an affected child has been precluded by the absence of detectable effects of the gene in single dose. Males affected with CF do not reproduce and affected females reproduce rarely. Despite this reduced ability of individuals with CF to have children, CF is a uniquely prevalent lethal single-gene disease in Caucasian populations. The basis for the cardinal signs of CF-chronic pulmonary obstruction, gastrointestinal malabsorption, and the sweat chloride abnormality-and their sequelae has been unexplained. The gene product responsible for these signs and symptoms of CF has been widely sought but not yet identified (1) .
Although CF is considered to be a generalized disease of exocrine glands (1) (2) (3) (4) , a number of laboratories including ours have used skin fibroblasts as a model system for CF studies. Fibroblasts are not exocrine cells but they do secrete their products by mechanisms similar to those operating in exocrine cells (5) . In addition, the donor's genotype is retained in cultured fibroblasts for many generations. For these reasons, skin fibroblasts were chosen as a model for CF studies. Using this cell model, we found that skin fibroblasts from subjects with CF in culture express premature senescence (6, 7) . To this precocious aging we related increased intracellular Ca2+ which occurs in cells from CF and obligate carriers (6, 8, 9) . The site of the altered intracellular Ca2+ pool was traced to mitochondria (10) .
Accumulation of Ca2+ by mitochondria is a highly complex and incompletely understood process. Numerous variables are involved. Perturbations of any one of several systems potentially could result in the altered mitochondrial Ca2+ pools in CF observed by us. One of the systems related to mitochondrial Ca2+ influx consists of the terminal steps of oxidation of metabolites because the uphill accumulation of Ca2+ in mitochondria is thought to be driven by a proton gradient generated during electron transport (11, 12) . Of the many possible explanations for our previous findings, we reasoned that the increased sequestration of Ca2+ in mitochondru from subjects with CF and from carriers might be a reflection of increased electron transport. If this were in fact the case, 02 consumption would be expected to be increased in these cells. We therefore examined 02 consumption in cells from CF patients and their ageand sex-matched controls (13 5 min and washed with 10 ml of cold Hanks' balanced salt solution at pH 7.4 containing bovine serum albumin (0.1 mg/ml) and dextrose (10 mg/ml). Aliquots (100 Al) of the washed cell suspension were taken for cell counting in a model ZBI Coulter Counter. The washed cells were again pelleted by centrifugation and resuspended in 1 ml of cold Hanks' solution. 02 consumption was measured polarographically on a cell suspension of 1 X 107 cells in a final volume of 3 ml by using an 02 electrode system (Clark model 53, Yellow Springs Instruments) (10).
In additional experiments, rotenone (Sigma) was used to specifically inhibit site 1 of the electron transport system. In these experiments the baseline 02 uptake rate was determined for each cell line. Prior to removal of the cells from the electrode chamber, 100 pl of 100 ,uM rotenone was added and 02 consumption was recorded. Preliminary experiments included the addition of 100 A1 of 0.1% KCN to assess the extent of inhibition caused by this mitochondrial electron transport inhibitor. NADH Dehydrogenase. Monolayers were grown to confluence. At the time of assay they were rinsed with 3 ml of trypsin/EDTA and then 5 ml of trypsin/EDTA was added and the monolayer was incubated at 370C for 10 min. Cells were removed by gentle shaking and transferred to a centrifuge tube containing 1 ml of fetal calf serum (GIBCO). An aliquot (100 1.l) was removed and suspended in 9.9 ml of Isoton II balanced electrolyte solution (CMS, Minneapolis, MN) for cell counting. The cell suspension was centrifuged at '410 X g for 5 supernatant was discarded, and the pellet was washed twice with 0.03 M potassium phosphate buffer (pH 7.6) at 0C. The cells were suspended in 2 ml of 0.12 M potassium phosphate buffer (pH 7.6) at 0C. After removal of a 150-,IA aliquot for protein analysis (15) the cell suspension was homogenized at 0C at approximately 10,000 rpm in a PT-10 Polytron (Brinkmann). The resulting homogenate was centrifuged at 1400 X g for 10 min and the supernatant was used for assays. Individual flasks yielded between 1.5 X 106 and 2.5 X 106 cells, the cell and enzyme activity yields from the three genotypes being equivalent.
The oxidation of NADH by homogenates was assayed in an Aminco-Bowman spectrophotofluorometer with potassium ferricyanide as an artificial electron acceptor (16 varied between 2.5 and 25 AM. Reaction mixture pH varied between 7.9 and 8.8. Reagents were mixed and incubated for 5 min at room temperature. Nonenzymatic reaction was recorded first, and then 100 ,l of whole cell extract was added to the reaction mixture to assay the oxidation of NADH. The reaction was assayed at room temperature. Activity of NADH dehydrogenase was expressed as A fluorescence (F)/min per mg of protein or cell. In some experiments, NADH dehydrogenase obtained from isolated mitochondria (10) was assayed.
RESULTS
02 Consumption. KCN completely abolished measurable 02 uptake in all cell lines tested. Mean (+SEM) 02 uptake (nmol 02/min per 108 cells) was greater in fibroblasts from CF subjects (328.7 i 28.2, n = 6) than in their controls (199.5 + 22.8, n = 6) and in those from heterozygote subjects (227.7 + 17.7, n = 8) than in their controls (156.3 i 15.6, n = 8 (P < 0.005, Student's t test in both comparisons).
At the dosage used, rotenone inhibited 02 consumption in all cell strains tested but the inhibitory effect was CF > HZ > controls (P < 0.005 in both comparisons, Student's t test). The inhibitory effect of rotenone on 02 consumption in the three genotypes is shown in Fig. 1 .
NADH Dehydrogenase. Maximal enzyme activity in cell homogenates occurred at pH 8.6 in CF strains and pH 8.0 in control strains (Fig. 2) . The clear and consistent difference in pH optima for NADH dehydrogenase in CF and control strains occurred at all passages tested (Table 1 ). In strains from obligate [The homogenation and fractionation of mitochondrial preparation has been described (10) .] Mitochondrial fractions were frozen and thawed three times to ensure membrane disruption prior to enzyme assay. The control cell strain had its highest activity at pH 8.0, whereas the CF cell strain has its highest activity at pH 8.6 . The carrier cell strain showed a broad peak with its optimum at pH 8.3 . Purity of the mitochondrial preparation was assayed by transmission electron microscopy and succinate dehydrogenase assay (10 (Fig. 2) . pH optima repeatedly were different in the three genotypes. In a blind experiment, carriers could be distinguished from their controls on the basis of this variable alone (Fig. 3) .
The effect of pH on NADH dehydrogenase activity in relatively pure mitochondrial preparations is shown in Fig. 4 DISCUSSION Because previously reported findings suggested that increased intracellular Ca2+ pools and°2 consumption occurred in mitochondria from CF and HZ strains and because cell strains of the three genotypes responded differently to rotenone, an inhibitor specific to site 1 of the mitochondrial electron transport system, we examined kinetics of mitochondrial NADH dehydrogenase, the site 1 enzyme. Consistent and significant kinetic differences in NADH dehydrogenase from CF, HZ, and control cell strains were observed. Enzyme from relatively pure mitochondrial preparations revealed the same pH optima differences in the three genotypes as was found in whole cell homogenates. pH optima in microsomal preparations (data not shown) did not coincide with those from whole cell extracts and did not differ among the three genotypes. We conclude, therefore, that the kinetic differences observed reflect mitochondrial derived enzyme.
Alterations in Km and pH optima of an enzyme oridinarily suggest protein variants (17) such as those usually associated with Mendelian traits. The NADH dehydrogenase system of mitochondria, however, is so complex, "perhaps the most complex of all flavoproteins" (18) , that analogy to other proteins may be inappropriate. In the preparations used here, no effort was made to remove membrane phospholipids which are integral to functioning mitochondrial NADH dehydrogenase (19) . Theoretically, therefore, the kinetic differences observed could be a reflection of altered amounts or types of mitochondrial phospholipid in cells of the three genotypes. In any case, the consistent difference in pH optima for NADH dehydrogenase activity between HZ (clinically normal in every way) and their controls precludes any pathological or therapeutic effect of CF as being responsible for the differences reported.
NADH Dehydrogenase. This system, the first of several energy-conserving sites in mitochondrial electron transport, has been extensively studied and reviewed (18) (19) (20) . We are not aware of a previous study of it in human fibroblasts. The enzyme system has been studied thoroughly in preparations from beef heart mitochondria and, to a lesser extent, in yeast (19) . Despite the considerable literature on this system, the mechanism of NADH oxidation, the functional organization of complex I in the inner mitochondrial membrane, and its molecular structure remain obscure (20) . Ubiquinone is the natural acceptor for electrons released in the oxidation of NADH, and ferricyanide is the most efficient artificial electron acceptor. The particulate preparation of the enzyme which includes mitochondrial inner membrane phospholipid is thought to most closely resemble the in vvo system and has been called complex I of the mitochondrial electron transport system (19) . Complex I contains also FMN, iron-sulfur groups, and substantial amounts of ubiquinone 10 (21) and has a molecular weight of approximately 8-8.5 X 105 (19) . The number of different proteins comprising complex I has been controversial. Hatefi and Stiggall (19) consider complex I to be a multienzyme complex. Singer and Edmondson (18) and Ragan (20) suggest that complex I is a multisubunit enzyme.
Despite the complexity and controversy that exist there are several important points of agreement concerning mitochondrial NADH dehydrogenase: (i) it is the site of entry of NADH into the respiratory chain; (ii) it catalyzes the dehydrogenation of NADH generated through oxidation of numerous NAD+-linked dehydrogenase reactions; (iii) it is the first of three en--ergy-conserving sites where ATP is formed; (iv) it is one of three sites of uphill Ca2+ influx into mitochondria; and (v) it is specifically inhibited by several agents including rotenone (18) (19) (20) (21) .
Pathogenesis of CF. The earliest lesion in exocrine tissues in CF is the microobstruction of glandular tissue by cellular products that are less soluble than those produced by normal cells (1) (2) (3) (4) . Dilatation of ducts (the "cysts") and fibrosis ensue.
These cystic and fibrotic lesions in the pancreas lead to failure of delivery of digestive enzymes to the gut and, in the lung, to chronic obstruction and infection. The potential role of Ca2+ in the production of exocrine products of decreased solubility has been suggested and demonstrated (22) . source of cytosolic Ca2+ in eukaryotic cells (23) . Secretory granules in exocrine glands have been showuto a4cum*t6 1 export from cells significant amounts of Ca2+ in conjunction with their secretory products (25, 26) . Furthermore, it has been reported that parotid acinar cells from patients with CF have significantly higher Ca2+ concentrations than do cells from controls (27) . It appears reasonable to us to conclude that significantly increased mitochondrial Ca2+ could be the source of increased Ca2+ in exocrine secretions in CF and that incorporation of increased Ca2+ in secretory granules is the basis of decreased solubility of otherwise normal secretory products. Data reported here suggest also that the basis for increased sequestration of Ca2+ in mitochondria in CF may be anomalous functioning of NADH dehydrogenase, the first of three sites in the respiratory chain associated with Ca2+ accumulation by these organelles. Conclusion. These rationalizations about CF pathogenesis aside, we have traced increased mitochondrial Ca2+ and 02 consumption in CF and HZ fibroblasts to NADH dehydrogenase. We have shown that cells from CF subjects and obligate CF carriers consistently and clearly differ from controls in kinetic characteristics of this enzyme system. We believe that an alteration in a portion of this complex enzyme system may be a fundamental expression of the genetic abnormality in this prevalent lethal disease.
